Compare URGN & CENTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | URGN | CENTA |
|---|---|---|
| Founded | 2004 | 1955 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Consumer Specialties |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 2.3B |
| IPO Year | 2016 | 1996 |
| Metric | URGN | CENTA |
|---|---|---|
| Price | $43.39 | $36.31 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 7 | 4 |
| Target Price | $29.29 | ★ $36.75 |
| AVG Volume (30 Days) | ★ 985.0K | 295.4K |
| Earning Date | 05-06-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 57.41 |
| EPS | N/A | ★ 2.84 |
| Revenue | $1,128,000.00 | ★ $3,129,100,000.00 |
| Revenue This Year | $129.09 | $1.60 |
| Revenue Next Year | $70.96 | $2.04 |
| P/E Ratio | ★ N/A | $13.10 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $15.86 | $25.97 |
| 52 Week High | $50.81 | $40.80 |
| Indicator | URGN | CENTA |
|---|---|---|
| Relative Strength Index (RSI) | 45.28 | 37.34 |
| Support Level | $18.25 | $33.34 |
| Resistance Level | $43.93 | $37.71 |
| Average True Range (ATR) | 1.82 | 0.88 |
| MACD | -0.90 | -0.20 |
| Stochastic Oscillator | 14.81 | 17.43 |
UroGen Pharma Ltd is a clinical-stage biotechnology firm specializing in solutions for urothelial and specialty cancers. The company has developed RTGel reverse-thermal hydrogel, a proprietary technology enhancing the therapeutic profiles of existing drugs by enabling sustained release. The company's flagship product, Jelmyto (mitomycin) for pyelocalyceal solution, along with Zusduri (mitomycin) for intravesical solution, targets non-surgical tumor ablation in forms of non-muscle invasive urothelial cancer. The revenue source for the company comes from sales of the Company's approved products, Jelmyto and Zusduri, principally conducted in the United States.
Central Garden & Pet Co offers solutions that support healthier pets, greener lawns, and thriving gardens. Its products include dog and cat treats, chews, toys, beds, containment, grooming supplies, aquatics, small animal and bird supplies, equine and livestock products, insect control solutions, grass seed, wild bird feed, fertilizers, pest controls, live plants, and packet seeds, sold under brands such as Aqueon, Nylabone, Kaytee, Farnam, Pennington, Ferry Morse, Amdro, and Sevin. The company operates through two segments, Pet and Garden, and sells through retailers, independent stores, eCommerce channels, and professional markets. It has sales and distribution operations mainly across the United States, with additional facilities in Canada and Mexico.